| Post-kala-azar dermal leishmaniasis EE Zijlstra, AM Musa, EAG Khalil, IM El Hassan, AM El-Hassan The Lancet infectious diseases 3 (2), 87-98, 2003 | 709 | 2003 |
| Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan EAG Khalil, AME Hassan, EE Zijlstra, MM Mukhtar, HW Ghalib, B Musa, ... The lancet 356 (9241), 1565-1569, 2000 | 294 | 2000 |
| Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan EE Zijlstra, Y Nur, P Desjeux, EAG Khalil, AM El‐Hassan, J Groen Tropical Medicine & International Health 6 (2), 108-113, 2001 | 268 | 2001 |
| First generation leishmaniasis vaccines: a review of field efficacy trials S Noazin, F Modabber, A Khamesipour, PG Smith, LH Moulton, K Nasseri, ... Vaccine 26 (52), 6759-6767, 2008 | 237 | 2008 |
| Evaluation of PCR for diagnosis of visceral leishmaniasis OF Osman, L Oskam, EE Zijlstra, NC Kroon, GJ Schoone, ET Khalil, ... Journal of clinical microbiology 35 (10), 2454-2457, 1997 | 213 | 1997 |
| rK39 Enzyme-Linked Immunosorbent Assay for Diagnosis of Leishmania donovani Infection EE Zijlstra, NS Daifalla, PA Kager, EAG Khalil, AM El-Hassan, SG Reed, ... Clinical Diagnostic Laboratory Immunology 5 (5), 717-720, 1998 | 181 | 1998 |
| Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial A Musa, E Khalil, A Hailu, J Olobo, M Balasegaram, R Omollo, T Edwards, ... PLoS neglected tropical diseases 6 (6), e1674, 2012 | 180 | 2012 |
| Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis S Noazin, A Khamesipour, LH Moulton, M Tanner, K Nasseri, F Modabber, ... Vaccine 27 (35), 4747-4753, 2009 | 170 | 2009 |
| Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial A Hailu, A Musa, M Wasunna, M Balasegaram, S Yifru, G Mengistu, ... PLoS neglected tropical diseases 4 (10), e709, 2010 | 156 | 2010 |
| High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis S Gasim, AM Elhassan, EAG Khalil, A Ismail, AMY Kadaru, A Kharazmi, ... Clinical & Experimental Immunology 111 (1), 64-69, 1998 | 156 | 1998 |
| SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan HS Mohamed, ME Ibrahim, EN Miller, JK White, HJ Cordell, ... European Journal of Human Genetics 12 (1), 66-74, 2004 | 128 | 2004 |
| Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study AM Musa, B Younis, A Fadlalla, C Royce, M Balasegaram, M Wasunna, ... PLoS neglected tropical diseases 4 (10), e855, 2010 | 121 | 2010 |
| Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment AM Musa, EAG Khalil, FAE Mahgoub, SHH Elgawi, F Modabber, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008 | 121 | 2008 |
| Post‐kala‐azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis EE Zijlstra, EAG Khalil, PA Kager, AM El‐Hassan British journal of dermatology 143 (1), 136-143, 2000 | 120 | 2000 |
| Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study AS Aljafari, EAG Khalil, KE Elsiddig, IA El Hag, ME Ibrahim, M Elsafi, ... Cytopathology 15 (1), 44-48, 2004 | 113 | 2004 |
| Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan EAG Khalil, EE Zijlstra, PA Kager, AM El Hassan Tropical Medicine & International Health 7 (1), 35-44, 2002 | 106 | 2002 |
| Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1 HS Mohamed, ME Ibrahim, EN Miller, CS Peacock, EAG Khalil, ... Genes & Immunity 4 (5), 351-355, 2003 | 105 | 2003 |
| Y chromosome lineage-and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan EN Miller, M Fadl, HS Mohamed, A Elzein, SE Jamieson, HJ Cordell, ... PLoS Genetics 3 (5), e71, 2007 | 94 | 2007 |
| Efficacy and safety of AmBisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial M Wasunna, S Njenga, M Balasegaram, N Alexander, R Omollo, ... PLoS neglected tropical diseases 10 (9), e0004880, 2016 | 89 | 2016 |
| Kala-azar in a high transmission focus: an ethnic and geographic dimension. ME Ibrahim, B Lambson, AO Yousif, NS Deifalla, DA Alnaiem, A Ismail, ... The American journal of tropical medicine and hygiene 61 (6), 941-944, 1999 | 88 | 1999 |
